Market Closed -
Other stock markets
|
After market 12:05:24 am | |||
9.405 EUR | -1.21% | 9.4 | -0.05% |
10/06 | Almirall: extension of indication in actinic keratosis | CF |
10/06 | Almirall’s Skin Disease Drug Gets US FDA Nod for Larger Treatment Area | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.63% | 212.9Cr | |
+55.01% | 81TCr | |
+43.62% | 64TCr | |
-7.52% | 35TCr | |
+16.43% | 33TCr | |
+8.89% | 30TCr | |
+16.30% | 25TCr | |
+2.41% | 22TCr | |
+12.47% | 22TCr | |
+8.32% | 17TCr |
- Stock Market
- Equities
- ALM Stock
- News Almirall, S.A.
- Transcript : Almirall, S.A., H1 2021 Earnings Call, Jul 26, 2021